Quick Answer
ProPhase Labs, Inc. reported Total Revenue of $6.77 million for the year ending 2024.
- ProPhase Labs, Inc. showed a decrease of -80.6% in Total Revenue from 2023 to 2024.
- This data is from ProPhase Labs, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $1.91 million | Q3 2017: $3.04 million | Q1 2018: $3.41 million | Q2 2018: $3.19 million | Q3 2018: $2.44 million | Q1 2019: $2.32 million | Q2 2019: $1.65 million | Q3 2019: $2.77 million | Q1 2020: $1.89 million | Q2 2020: $3.62 million | Q3 2020: $3.84 million | Q1 2021: $15.27 million | Q2 2021: $9.14 million | Q3 2021: $9.47 million | Q1 2022: $47.53 million | Q2 2022: $29.09 million | Q3 2022: $24.20 million | Q1 2023: $19.30 million | Q2 2023: $13.22 million | Q3 2023: $8.37 million | Q1 2024: $2.36 million | Q2 2024: $1.50 million | Q3 2024: $1.42 million | Q1 2025: $1.43 million | Q2 2025: $1.25 million | Q3 2025: $883.0 thousand.
- Over the full 8 years of available data (2017 to 2024), ProPhase Labs, Inc.'s Total Revenue has declined by 31.4%.
- Historical annual values: Fiscal year 2024: $6.77 million | Fiscal year 2023: $34.98 million | Fiscal year 2022: $122.65 million | Fiscal year 2021: $79.04 million | Fiscal year 2020: $14.51 million | Fiscal year 2019: $9.88 million | Fiscal year 2018: $13.13 million | Fiscal year 2017: $9.87 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: